The mortality rate for cervix uteri malignant neoplasms in Mexico stood at 6.2 per hundred thousand women in 2023. The forecasted data for the period from 2024 to 2028 shows that the mortality rate is expected to slightly increase to 6.3 per hundred thousand women beginning in 2025 and remain stable through 2028. The year-on-year percentage change from 2023 to 2024 represents an approximate increase of 1.6%, while the subsequent years show no variation, with the mortality rate holding steady at 6.3 per hundred thousand women. Over the next five years, the compound annual growth rate (CAGR) is expected to level out at a minimal increase, reflecting the forecasting data.
Future trends to watch for include advancements in cervical cancer screening and vaccination programs, which could affect the mortality rates. Additionally, potential shifts in healthcare policies, access to medical care, and public health initiatives in Mexico may play critical roles in influencing these rates over the forecasted period.
